U.S. market Open. Closes in 2 hours 52 minutes

GMAB | Genmab A/S Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for GMAB we got that it has strong fundamentals where Valuation is considered to be undervalued, Profitability is very wealthy, Growth is exceptionally good and Health is very strong.

Valuation (76%)

Company Industry
P/E Ratio (TTM) 18.68 -23.05
PEG Ratio (TTM) 14.18 15.47
P/S Ratio (TTM) 5.34 49.46
P/B Ratio (TTM) 3.32 18.87
P/FCF Ratio (TTM) 15.55 -3.27
Price to 5YR AVG Earnings Ratio 3.82 -3.55
Price to 5YR AVG FCF Ratio 3.69 -9.37

Profitability (80%)

Company Industry
ROA (TTM) 14.25% -5.14%
ROE (TTM) 17.44% 16.69%
Net Profit Margin (TTM) 29.01% -1,583.93%
ROIC 5YR AVG 32.76% 15.15%

Growth (100%)

4QTR AVG 3YR AVG 5YR AVG
EPS 25.45% 39.15% 36.37%
Revenue 7.64% 49.90% 46.93%
Net Income 25.06% 42.98% 38.63%
Cash Flow 84.94% 116.82% 102.94%

Health (74%)

Company Industry
Current Ratio (TTM) 5.03 6.13
Quick Ratio (TTM) 5.02 5.85
D/E Ratio (TTM) 0.03 -15.81
Interest Coverage (TTM) 150.10 -1.57
Piotroski F-Score 5 5
Altman Z-Score 3.49 14.12
LTL to 5YR AVG FCF 0.17 0.17
Shares Outstanding Growth 5YR AVG 1.30% 123.44%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙